. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep. 2003 Nov 1;26(7):893-901. PubMed.


Please login to recommend the paper.


Make a Comment

To make a comment you must login or register.

Comments on this content

  1. Dosages of 2.5 and 3 milligrams of melatonin produce short sleep and nightmares followed by drowsiness. The experiment should be repeated with more physiological dosages of 0.1 or 0.2 milligrams.

    The Hormone Handbook, by Thierry Hertoghe MD

This paper appears in the following:


  1. No Rest for the Weary: Melatonin Fails Alzheimer's Trial